COMPLETED

A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the present study is to use computationally driven models of speech understanding in cochlear implant (CI) users to guide the search for which combination of active electrodes can yield the best speech understanding for a specific patient. It is hypothesized that model-recommended settings will result in significantly better speech understanding than standard-of-care settings.

Official Title

A Computational Approach to Optimal Deactivation of Cochlear Implant Electrodes

Quick Facts

Study Start:2022-05-01
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05219474

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * must be older than the age of 18
  2. * implanted unilaterally with CI with at least 1 year of experience
  3. * no diagnosis of any other communicative or cognitive disorder.
  4. * English-speaking
  5. * willingness and ability to provide informed consent
  6. * must be older than age of 18
  7. * no diagnosis of any other communicative or cognitive disorder.
  8. * English-speaking
  9. * willingness and ability to provide informed consent
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Elad Sagi, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Elad Sagi, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-01
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2022-05-01
Study Completion Date2025-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • Hearing Loss